What Sheller does

Sheller, P.C. is a Philadelphia-based plaintiff-side law firm founded in 1985 by Stephen A. Sheller, with a single office at 1515 Market Street, Suite 1100. The firm operates across five practice areas: Class Action & Mass Tort, Dangerous Drugs, Personal Injury, Product Liability, and Whistleblower/Qui Tam litigation. It represents individual plaintiffs nationwide in cases involving defective products, dangerous pharmaceuticals, medical devices, consumer fraud, and False Claims Act qui tam matters, often against large pharmaceutical and corporate defendants.

The firm generates revenue through contingency fee arrangements, offering free initial consultations and receiving a percentage of recoveries only on successful outcomes. It has no external investors, parent company, or disclosed funding rounds, and is structured as a private professional corporation. The named attorney bench is small (Stephen A. Sheller as Founding Partner, Jamie L. Sheller as Of Counsel, and Joseph Trautwein, a former DOJ attorney), within an overall headcount band of 11-50 employees.

Sheller's competitive position rests on a multi-decade track record of high-profile outcomes, including over $6.4 billion in whistleblower/qui tam settlements, a $10.1 billion verdict against Philip Morris in tobacco 'lite' litigation, and significant Risperdal verdicts including $70 million and $8 billion in punitive damages. Distribution is direct-to-consumer through phone and website intake, supplemented by co-counsel relationships with Kline & Specter and Arnold & Itkin LLP for mass tort dockets. Marketing relies on earned media, YouTube video content, and the Sheller Family Foundation's community profile in Philadelphia.

Name

Sheller

Legal name

Sheller, P.C.

Website

https://sheller.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

11–50 employees

Short description

Sheller, P.C. is a Philadelphia-based plaintiff-side law firm representing individual clients nationwide in whistleblower/qui tam, dangerous drug, product liability, mass tort, and personal injury cases on a contingency fee basis.

Ownership category

akta.pro rank

Product category

Plaintiff Law Firm / Legal Services

NAICS

Offices of Lawyers (541110), Legal Services (5411)

SIC

Services-Legal Services (8111)

akta.pro primary industry

Personal Injury & Insurance Defense (BPAHAAAM)

Keywords

• Plaintiff law firm
• Qui tam whistleblower
• Mass tort litigation
• Product liability law
• Personal injury representation

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Legal Services - Contingency Fee: The firm represents clients in personal injury, product liability, whistleblower, and class action litigation. Standard contingency fee arrangement where attorneys receive a percentage of recovered damages only if the case is successful. No upfront costs to clients for initial consultations.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Sheller, P.C. is a plaintiff-side consumer and patient law firm representing individuals in five core practice areas: Whistleblower/Qui Tam False Claims Act cases, Class Action and Mass Tort litigation, Dangerous Drugs claims, Product Liability suits, and Personal Injury matters. The firm operates on a contingency fee basis with free initial consultations and represents clients nationwide in cases against pharmaceutical, medical device, and other large corporate defendants.

Product overview

Sheller, P.C. is a consumer and patient plaintiff law firm offering five core legal service practice areas: Class Action & Mass Tort litigation, Dangerous Drugs cases, Personal Injury claims, Product Liability representation, and Whistleblower/Qui Tam services. The firm specializes in pharmaceutical litigation, having recovered over $6.4 billion in whistleblower settlements, and represents victims of defective products, drugs, medical devices, and corporate wrongdoing. The practice areas function as distinct but complementary service offerings united by the firm's focus on protecting consumer and patient rights.

Differentiator

Problem solved

Functional benefit

Products and services

• Class Action & Mass Tort

Quantifiable outcome

• Recovered over $6.4 billion for the U.S. government in whistleblower/qui tam settlements
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Kline & SpectercoreStrategic or Co-development PartnerCo-counsel relationship in complex Risperdal mass tort litigation. Firms have litigated together in multiple high-profile cases including the $70 million Yount verdict, $500,000 Stange verdict, and $1.75 million Murray verdict. Thomas Kline of Kline & Specter led litigation in multiple cases.
• Arnold & Itkin LLPcoreStrategic or Co-development PartnerCo-counsel partnership in Risperdal litigation representing plaintiffs nationwide. Jason Itkin represented A.Y. alongside Sheller and Kline & Specter in $70 million verdict case. Firm based in Houston, Texas.
• Mural Arts PhiladelphiaminorStrategic or Co-development PartnerSheller Family Foundation long-time supporter of Mural Arts' Color Me Back Same Day Pay Program addressing economic insecurity. Stephen and Sandy Sheller honored at 2021 Wall Ball event.
• Sheller Family FoundationminorOthersPhilanthropic foundation established by Stephen and Sandra Sheller. Supports Stephen and Sandra Sheller Center for Social Justice at Temple University, 11th Street Family Health Services Center at Drexel University, and Mural Arts Philadelphia programs.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kline & Specter: Philadelphia-based plaintiffs firm co-counseled with Sheller on Risperdal mass tort cases including the $70M Yount verdict. Both firms focus on catastrophic personal injury, mass tort, and product liability, and compete for similar plaintiff-side work in Pennsylvania and nationwide.
• Motley Rice: National plaintiffs firm with deep mass tort, whistleblower/FCA, and class action practices. Directly competes with Sheller in pharmaceutical whistleblower/qui tam work and represents similar plaintiff populations in opioid and drug-injury mass torts.
• Bernstein Litowitz Berger & Grossmann: Plaintiffs firm specializing in securities class actions, whistleblower/FCA cases, and complex litigation. Directly competes with Sheller in high-stakes qui tam whistleblower work and has secured top-tier FCA settlements comparable to Sheller's track record.
• Constantine Cannon: Specialist plaintiffs firm focused on whistleblower/FCA qui tam work, antitrust, and financial fraud. Direct competitor for relator-side FCA cases, especially in healthcare fraud — the same domain that produced most of Sheller's headline settlements.
• Arnold & Itkin LLP: Houston-based plaintiffs firm that has served as co-counsel with Sheller on Risperdal cases (e.g., $70M Yount verdict). Comparable practice in catastrophic injury, product liability, and mass tort with similar contingency-fee business model.
• Napoli Shkolnik: Plaintiffs firm with deep mass tort and pharmaceutical litigation practice. Competes for plaintiff-side drug injury cases (including Risperdal-style claims) and pursues similar mass tort/mDL strategies.
• Lieff Cabraser Heimann & Bernstein: National class action and mass tort plaintiffs firm with active pharmaceutical and consumer fraud litigation. Comparable contingency-fee model and target clients in class action/mass tort work overlapping Sheller's practice areas.
• Weitz & Luxenberg: New York-based mass tort and personal injury powerhouse with active pharmaceutical/dangerous drug litigation. Competes with Sheller for plaintiff-side mass tort and product liability cases, including drug injury portfolios.

Emerging players

• Pogust Braslow & Millrood: Growing mass tort plaintiffs firm with active pharmaceutical and consumer litigation. Smaller and more recent but pursues similar mass tort strategies and represents overlapping plaintiff populations in drug-injury matters.

Broad incumbents

• Robins Kaplan: Large national plaintiffs firm with mass tort, class action, and personal injury practices. Broader portfolio than Sheller but directly overlaps on pharmaceutical mass tort and consumer class action work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/ShellerPC
• LinkedInlinkedin.com/company/sheller-p.c.

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sheller